0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Spotlight Jul 27

Featured Spotlight

Assessment of BDBV Diagnostics, PARTNERS Trial, and Outbreak Dynamics in Ituri as of Early July 2026

  1. WHO Guidelines for Clinical Management of Filovirus Disease (2026) (iris.who.int) | 26d ago
  2. Use of Ebola Vaccines — Worldwide, 2021–2023 | MMWR - CDC (cdc.gov) | 65d ago
  3. Africa CDC: No Approved Vaccine for Ebola-Sudan Strain, Trial Underway (facebook.com) | 65d ago
  4. Development of Pandemic Vaccines: ERVEBO Case Study (pmc.ncbi.nlm.nih.gov) | 65d ago
  5. WHO R&D Blueprint Technical Advisory Group prioritizes therapeutics for Bundibugyo virus disease (iris.who.int) | 62d ago
  6. WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 63d ago
  7. Ebola Virus Disease Vaccines – WHO Q&A (who.int) | 65d ago
  8. Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov) | 65d ago
  9. CDC Clinical Guidance for Ebola Bundibugyo Virus: Outbreak Overview and Recommendations for Clinicians (May 2026) (cdc.gov) | 60d ago
  10. rVSV-ZEBOV (Ervebo) Vaccine: Comprehensive Overview (en.wikipedia.org) | 62d ago
  11. FDA approves Ebanga for Zaire ebolavirus treatment (fda.gov) | 2044d ago
  12. WHO advises against routine use of Ervebo vaccine for Bundibugyo virus outbreak, recommends research rather than programmatic deployment (iris.who.int) | 60d ago
  13. PARTNERS clinical trial begins enrolment for Bundibugyo virus disease treatments in the Democratic Republic of the Congo (who.int) | 25d ago
  14. Bundibugyo ebolavirus outbreak highlights spillover risks and vaccine gaps in western Uganda (news.mongabay.com) | 61d ago
  15. ERVEBO (Ebola Zaire Vaccine, Live) – Prescribing Information (merck.com) | 117d ago
  16. WHO Technical Advisory Group prioritizes therapeutics for Bundibugyo virus disease (who.int) | 60d ago
  17. WHO Expert Groups Assess Candidate Treatments and Vaccines for Bundibugyo Virus Disease Outbreak in DRC and Uganda (who.int) | 60d ago
  18. WHO releases first comprehensive clinical guidelines for filovirus disease management (who.int) | 40d ago
  19. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 65d ago
  20. WHO publishes clinical management guidelines for filovirus disease (Ebola, Marburg, Sudan, Bundibugyo, Taï Forest) (who.int) | 46d ago
  21. Ebola Vaccines Exist, But Not for Bundibugyo Strain in Current Uganda Outbreak (scientificamerican.com) | 65d ago
  22. WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 60d ago
  23. Ervebo vaccine: EMA EPAR summary for EU authorization (ema.europa.eu) | 62d ago
  24. WHO Technical Advisory Group Prioritizes Vaccine Candidates for Bundibugyo Virus Disease in DRC and Uganda (who.int) | 60d ago
  25. WHO Publishes Submission Requirements for Emergency Use Listing of Bundibugyo Virus Diagnostic Tests (extranet.who.int) | 52d ago
  26. US CDC Issues Interim Final Rule to Suspend Entry of Persons from Ebola-Affected Countries (govinfo.gov) | 61d ago
  27. WHO adds first diagnostic test for Ebola Bundibugyo virus to Emergency Use Listing (extranet.who.int) | 373d ago
  28. Ebola virus disease: an update on post-exposure prophylaxis – PMC (pmc.ncbi.nlm.nih.gov) | 62d ago
  29. Delayed FVM04/CA45 monoclonal antibody cocktail fully protects cynomolgus macaques against Sudan virus (journals.asm.org) | 62d ago
  30. Ebola outbreak in DR Congo: Reflections from West African survivor highlight need for speed, community trust, and vaccine development for Bundibugyo species (bbc.co.uk) | 66d ago
  31. WHO adds first molecular diagnostic test for Ebola Bundibugyo virus to Emergency Use Listing (who.int) | 25d ago
  32. MSF highlights diagnostic and treatment gaps in Bundibugyo virus outbreak in Uganda (doctorswithoutborders.org) | 62d ago
  33. Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com) | 66d ago
  34. CEPI's role in developing vaccines for epidemic-prone infectious diseases (law.berkeley.edu) | 63d ago
  35. Bundibugyo virus causing deadly Ebola outbreak in DRC and Uganda has no licensed vaccine (gavi.org) | 66d ago
  36. FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 62d ago
  37. No approved vaccine exists for Bundibugyo Ebola strain, impacting outbreak response (washingtonpost.com) | 67d ago
  38. WHO selects maftivimab, remdesivir, and MBP134 as priority Ebola drugs for trials (pharmaphorum.com) | 59d ago
  39. WHO Invites Manufacturers to Submit Diagnostic Tests for Ebola Bundibugyo Virus for Emergency Use Listing (extranet.who.int) | 59d ago
  40. WHO reports 906 suspected Ebola cases, 223 deaths in DR Congo from Bundibugyo strain (indiatoday.in) | 59d ago
  41. CDC Clinical Guidance for Ebola in Pregnant Women (cdc.gov) | 815d ago
  42. Bundibugyo Ebola virus outbreak in DRC and Uganda: no approved countermeasures (wellcome.org) | 59d ago
  43. WHO Emergency Use Listing Procedure Revision (August 2022) (extranet.who.int) | 1448d ago
  44. Bundibugyo Ebola outbreak: A harsh reminder of the need for broad vaccine strategies (bioworld.com) | 67d ago
  45. FDA Expands ERVEBO Approval to Children Aged 12 Months and Older (merck.com) | 62d ago
  46. Bundibugyo virus: Rare Ebola species with no approved vaccines or therapeutics (scientificamerican.com) | 66d ago
  47. US doctor infected with Ebola in DR Congo treated in Berlin (bbc.co.uk) | 70d ago
  48. WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 62d ago
  49. Ebanga™: The most recent FDA-approved drug for treating Ebola (pmc.ncbi.nlm.nih.gov) | 65d ago
  50. Overview of experimental vaccines and treatments for Bundibugyo Ebola in DRC outbreak (cnbcafrica.com) | 59d ago
Showing page 1 of 3 (115 total results)
← Prev Next →